Another group implanted DU145 prostate cancer cells expressing doxycycline-inducible shRNAs into the prostates of immunocompromised mice and found that SCD1 ablation resulted in a significant increase in life span and a substantial attenuation of tumor growth in the early doxycycline treatment regimen [167]. Here, SCD is linked to prostate carcinoma.